RedHill Biopharma Ltd. (RDHL) NASDAQ
1.03
+0.005(+0.49%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.03
+0.005(+0.49%)
Currency In USD
| Market Cap | 15.3M |
| Enterprise Value | 11.04M |
| P/E Ratio | -0.28 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.5 |
| Price/Book Ratio | -0.42 |
| Enterprise/Revenue | 0.11 |
| Enterprise/EBITDA | -0.13 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -0.99 |
| Operating Margin | -1.09 |
| Return On Assets | -0.37 |
| Return On Equity | 1.49 |
| Revenue | 8.04M |
| Revenue/Share | 3.78 |
| Gross Profit | 4.85M |
| EBITDA | -7.59M |
| Net Income | -8.27M |
| Diluted EPS | -7 |
| Total Cash | 2.87M |
| Total Cash/Share | 1.59 |
| Total Debt | 214,000 |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.56 |
| Book Value Per Share | -2.45 |
| 52-Week Change | -52.53 |
| 52-Week High | 3.31 |
| 52-Week Low | 0.71 |
| Moving Average 50 Days | 0.89 |
| Moving Average 200 Days | 1.28 |
| Average Volume | 38,927 |
| Shares Outstanding | 3.33M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 20, 2024 |